Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms

Beni-Suef University60 enrolled

Overview

Our study included 60 patients with idiopathic OAB and treated with solifenacin 5mg twice daily for one month. After improvement of their condition, we divided the responders into 2 groups, group I stopped the drug suddenly, while group II underwent gradual weaning of the drug.

We started an open-label, prospective, two-arm, randomized controlled trial at Beni-Suef University, from January 2018 to January 2019, including 60 patients suffering from OAB symptoms. Patients were recently diagnosed with idiopathic OAB which was not treated prior to enrollment. All participants signed written informed consents. The study protocol was approved by the ethics committee of our faculty. Patients were allocated into 2 equal groups (30 patients in each group) according to a computer-generated random numeric table after exclusion of those who are not eligible or refused to be included in the study

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Voiding Disorders

Interventions

Solifenacin Succinate 5 MGDRUG

gradual weaning of drug vs. stopping

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * OAB patients. * Recently diagnosed. Exclusion Criteria: * Previous trials of treatment * UTI, stones, tumors, or Infravesical obstruction.

Locations (1)

Beni-Suef University

Banī Suwayf, Beni Suweif Governorate, Egypt

Outcomes

Primary Outcomes

improvement

decrease voiding times

Time frame: 1 month

Secondary Outcomes

recurrence of symptoms

increase in voiding times after improvement

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.